Chamas for Change: Impact of the COVID-19 Pandemic

April 21, 2023 updated by: Astrid Christoffersen-Deb, Moi University

Chamas For Change: A Gender-Responsive And Microfinance-Based Approach To Empowering Women And Building Resilience To Health Emergencies in Kenya

In Kenya, the chamas strategy (a peer support approach aimed at improving MNCH and reducing gender and social inequalities) has been shown to significantly improve maternal and child health outcomes while also providing social and financial support to participating women. However, the COVID-19 pandemic caused significant disruptions in women's work and MNCH services around the world due to reallocation of health care resources, COVID-19 fears, transportation restrictions, and lockdowns. These consequences appeared to disproportionately affect the poor, particularly poor women. The purpose of this participatory action design study is to determine how Chamas participation intersected with other factors to mitigate the effects of the COVID-19 pandemic on the health and economic well-being of women and children.

Study Overview

Status

Enrolling by invitation

Conditions

Detailed Description

The study objectives are:

To evaluate the effect of Chama participation on mitigating the effects of the pandemic on social and gender equity.

  • Impact on economic status (assessed using the changes in the Poverty Probability index scores)
  • Impact on health service utilization and behaviours (assessed using enrollment in the national health insurance scheme, number of ANC visits attended, facility delivery, maternal death, newborn death, infant death, exclusive breastfeeding, number of children fully immunized at age 1)
  • Social attitudes and well-being (assessed using, attitude towards harsh punishment of children, level of parental stress)
  • COVID-19 related information (assessed using COVID-19 infection, COVID-19 vaccination, and effects of COVID restrictions)

To use an equity-centered design process and narrative approach to share research findings.

The research team intends to evaluate women's experiences during the pandemic using a mixed method approach and a participatory action design method. The focus will be on 3 study cohorts: (1) women who participated in Chamas throughout the pandemic, (2) women who left Chamas during the pandemic, (3) women whose communities were randomized to not receive the Chamas intervention. To better understand the effects of Chama participation on study outcomes, we will conduct an interviewer-administered survey among the described cohorts of women. This will be followed by qualitative studies to contextualize the study findings and investigate gender dynamics as social processes. Focus group discussions (FGDs) and key informant interviews (KIIs) will be conducted to further investigate our study cohort's experiences during the pandemic and identify strategies used by participants to mitigate the negative effects of the pandemic and its associated restrictions.

Study Type

Observational

Enrollment (Anticipated)

444

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kiminini, Kenya
        • Trans Nzoia county
      • Kitale, Kenya
        • Trans-Nzoia County

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 50 years (Child, Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

This research will be conducted in Trans-Nzoia County among the 1400 women that participated in the 2021 RCT study. The following groups will be included in our study population.

  • RCT women who participated in Chamas throughout the pandemic.
  • Women who left Chamas after March 12, 2020, the date the first case of COVID-19 was discovered in Kenya.
  • Women whose communities were randomly assigned not to use Chamas during the RCT.
  • CHVs in communities that had or did not have Chamas operating during the pandemic.
  • County health officials.
  • Fathers participating in Chama cha Babatoto.
  • Adolescent girls are currently participating in Chamas adapted for adolescents.

Description

Inclusion Criteria:

  • Women who participated in the 2021 Chamas study in Western Kenya

Exclusion Criteria:

  • Women who did not participate in the 2021 study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Completed Chamas program
women who participated in Chamas throughout the pandemic
Chamas is a community health volunteer (CHV)-led group programme that engages women during pregnancy and the first 1000 days of their child's life. The strategy focuses on promoting maternal, newborn, and child health (MNCH) by providing health education, peer support, and opportunities to access financial capital, all while addressing inequities that perpetuate poor outcomes.
Did not complete Chamas program
women who left Chamas during the pandemic
Chamas is a community health volunteer (CHV)-led group programme that engages women during pregnancy and the first 1000 days of their child's life. The strategy focuses on promoting maternal, newborn, and child health (MNCH) by providing health education, peer support, and opportunities to access financial capital, all while addressing inequities that perpetuate poor outcomes.
Did not participate in Chamas program
women whose communities were randomized to not receive the Chamas intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Economic Status
Time Frame: 1 year
Impact of COVID-19 pandemic on the women's economic well-being based on Poverty property Index (PPI) scores obtained from 10 questions in the questionnaire. The PPI is a relative scale in which each response is assigned a value, and the sum of the values is the participant's PPI score. The participant's PPI is then compared with the country level score using the "look-up table" for the country (Kenya) to determine the participant's likelihood of being poor. The investigators will compare the PPI scores at the post-pandemic period between the three cohorts in the study.
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health insurance uptake
Time Frame: 1 year
Enrolment in health insurance based on questionnaire response.
1 year
Health service utilization
Time Frame: 1 year
Use of health services during the COVID-19 pandemic based on questionnaire response to questions assessing use of healthcare services during the COVID-19 pandemic.
1 year
Social impact of COVID19
Time Frame: 1 year
Parenting stress based on parental stress index scale scores in questionnaire. Overall possible scores on the scale range from 18 - 90. The higher the score, the higher the measured level of Parental stress
1 year
Attitudes towards Harsh punishment
Time Frame: 1 year
Attitude to child punishment based on questionnaire response.
1 year
COVID-19 experiences of key informants
Time Frame: 1 year
Experiences of the community during the COVID pandemic from the perspective of key informants will be explored based on qualitative interviews. Questions to explore how different genders experienced the pandemic will be specifically explored. The gender considerations will include an assessment of how gender interacts with resource access, the roles each gender plays in society, societal expectations, and power dynamics. It also includes evaluating the ways in which gender power relations manifest to create inequities and/or differences in experiences during the pandemic.
1 year
COVID-19 experiences
Time Frame: 1 year
Experiences of the community during the COVID pandemic from the perspective of the three cohorts of women in the study will be explored based on qualitative focus group discussions. Questions to explore how different genders experienced the pandemic will be specifically explored. The gender considerations will include an assessment of how gender interacts with resource access, the roles each gender plays in society, societal expectations, and power dynamics. It also includes evaluating the ways in which gender power relations manifest to create inequities and/or differences in experiences during the pandemic.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Julia Songok, AMPATH Kenya
  • Study Director: Michael Scanlon, Indiana University
  • Study Director: Laura Ruhl, Indiana University
  • Study Director: Julie Thorne, University of Toronto
  • Study Director: Violet Naanyu, Moi University
  • Study Director: Sammy Masibo, Trans Nzoia county government

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 14, 2023

Primary Completion (Anticipated)

March 13, 2024

Study Completion (Anticipated)

March 13, 2025

Study Registration Dates

First Submitted

March 23, 2023

First Submitted That Met QC Criteria

March 23, 2023

First Posted (Actual)

March 28, 2023

Study Record Updates

Last Update Posted (Actual)

April 25, 2023

Last Update Submitted That Met QC Criteria

April 21, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gender Equity

Clinical Trials on Chamas cha MamaToto program

  • Moi University
    AbbVie; University of Toronto; Indiana University; Grand Challenges Canada
    Unknown
    Pregnancy Related
    Kenya
Subscribe